SCHEMBL25003126

SCHEMBL25003126

CCOc1ccc(-c2nccc(C(=O)NN)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.51
▸ KMT2A Q03164 3/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ MAPT P10636 3/20 0.49
▸ ADORA3 P0DMS8 1/20 0.47
▸ PLK1 P53350 1/20 0.47
▸ LMNA P02545 2/20 0.46
▸ PARP10 Q53GL7 1/20 0.45
▸ NPC1 O15118 3/20 0.45
▸ RAB9A P51151 3/20 0.45
▸ PKM P14618 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ MITF O75030 1/20 0.45
▸ TP53 P04637 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.44
▸ ACACB O00763 1/20 0.44
▸ PPARD Q03181 1/20 0.44
▸ PPARA Q07869 1/20 0.44
▸ XDH P47989 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25003134 0.90 NPC1 (0.51) ALDH1A1KMT2AMEN1MAPTLMNA
SCHEMBL25003794 0.90 PLK1 (0.49) ALDH1A1KMT2AMEN1MAPTPLK1
SCHEMBL25003826 0.88 CA1 (0.54) ALDH1A1KMT2AMEN1MAPTLMNA
SCHEMBL25002930 0.85 RAB9A (0.49) ALDH1A1KMT2AMAPTADORA3PLK1
SCHEMBL25003142 0.84 ALDH1A1 (0.53) ALDH1A1KMT2AMEN1MAPTLMNA
SCHEMBL25003153 0.82 KMT2A (0.48) KMT2AMEN1ADORA3NPC1RAB9A
SCHEMBL25003137 0.81 ALDH1A1 (0.56) ALDH1A1KMT2AMAPTPLK1LMNA
SCHEMBL25003131 0.80 MAP4K4 (0.55) ALDH1A1KMT2AMEN1MAPTLMNA
SCHEMBL25003827 0.79 FDPS (0.46) ALDH1A1KMT2AMEN1MAPTLMNA
SCHEMBL25003805 0.78 ALDH1A1 (0.57) ALDH1A1MAPTADORA3NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023010192-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS EUROFARMA LABORATÓRIOS S.A. (BR) 2023-02-09 — — WO disclosed
Send feedback